Tiago Fauth Analyst Performance

Director - Equity Research Small/Mid Cap Biotechnology at Wells Fargo & Company

Tiago Fauth is a stock analyst at Wells Fargo & Company in the healthcare sector, covering 28 publicly traded companies. Over the past year, Tiago Fauth has issued 33 stock ratings, including strong buy and buy recommendations. While full access to Tiago Fauth's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tiago Fauth's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
83 Last 6 Years
Buy Recommendations
81.82% 63 Buy Ratings
Companies Covered
28 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy19.5%15 ratings
Buy62.3%48 ratings
Hold16.9%13 ratings
Sell1.3%1 ratings

Out of 77 total stock ratings issued by Tiago Fauth at Wells Fargo & Company, the majority (62.3%) have been Buy recommendations, followed by 19.5% Strong Buy, 16.9% Hold, and 1.3% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
28 companies

Tiago Fauth, an analyst at Wells Fargo & Company, currently covers 28 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
28 companies
100.0%

Tiago Fauth of Wells Fargo & Company specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
23 companies
82.1%
PHARMACEUTICALS
5 companies
17.9%

Tiago Fauth's Ratings History at Wells Fargo & Company

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
11/9/2026Reiterated Rating$31.00$54.00Outperform
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
11/4/2026Set Price Target$607.88$720.00
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
11/4/2026Set Price Target$25.97$73.00
CAMP4 Therapeutics Corporation stock logo
CAMP
CAMP4 Therapeutics
10/23/2026Initiated Coverage$3.39$10.00Strong-Buy
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
10/23/2026Initiated Coverage$8.82$14.00Outperform
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
10/20/2026Reiterated Rating$29.38$86.00Strong-Buy
Tonix Pharmaceuticals Holding Corp. stock logo
TNXP
Tonix Pharmaceuticals
10/20/2026Reiterated Rating$5.92Strong-Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
10/20/2026Set Price Target$44.89$79.00
Quince Therapeutics, Inc. stock logo
QNCX
Quince Therapeutics
10/9/2026Initiated Coverage$29.36$72.00Outperform
Avalyn Pharma Inc. stock logo
AVLN
Avalyn Pharma
10/2/2026Initiated Coverage$27.42$60.00Outperform
Avalyn Pharma Inc. stock logo
AVLN
Avalyn Pharma
10/2/2026Initiated Coverage$28.13$60.00Moderate Buy
Seaport Therapeutics, Inc. stock logo
SPTX
Seaport Therapeutics
9/25/2026Initiated Coverage$21.12$46.00Strong-Buy
Seaport Therapeutics, Inc. stock logo
SPTX
Seaport Therapeutics
9/25/2026Set Price Target$21.12$46.00
Seaport Therapeutics, Inc. stock logo
SPTX
Seaport Therapeutics
9/25/2026Initiated Coverage$21.52$46.00Strong-Buy
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
9/22/2026Reiterated Rating$41.47Strong-Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
9/8/2026Reiterated Rating$56.40$84.00Outperform
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
8/17/2026Reiterated Rating$47.42$75.00Strong-Buy
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
8/14/2026Set Price Target$11.36$31.00
Polaryx Therapeutics, Inc. stock logo
PLYX
Polaryx Therapeutics
8/13/2026Initiated Coverage$2.23$6.00Strong-Buy
Tonix Pharmaceuticals Holding Corp. stock logo
TNXP
Tonix Pharmaceuticals
8/10/2026Reiterated Rating$12.50$27.00Strong-Buy
Tectonic Therapeutic, Inc. stock logo
TECX
Tectonic Therapeutic
8/7/2026Lower Price Target$31.37$93.00Overweight
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
7/9/2026Set Price Target$64.51$87.00
Tonix Pharmaceuticals Holding Corp. stock logo
TNXP
Tonix Pharmaceuticals
6/24/2026Initiated Coverage$12.10$26.00Strong-Buy
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
6/24/2026Initiated Coverage$30.65$46.00Strong-Buy
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
6/24/2026Upgrade$31.96Strong-Buy
Tonix Pharmaceuticals Holding Corp. stock logo
TNXP
Tonix Pharmaceuticals
6/24/2026Upgrade$11.98Strong-Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
4/10/2026Initiated Coverage$75.28$104.00Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
4/10/2026Initiated Coverage$70.85$108.00Outperform
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
4/10/2026Initiated Coverage$34.22$66.00Strong-Buy
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
4/9/2026Initiated Coverage$68.69Moderate Buy
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
4/9/2026Initiated Coverage$34.17Strong-Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
4/9/2026Upgrade$76.76Moderate Buy
Insmed, Inc. stock logo
INSM
Insmed
12/16/2025Boost Price Target$196.92$234.00Overweight
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
11/5/2025Boost Price Target$67.72$93.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
10/31/2025Boost Price Target$194.22$217.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
10/20/2025Initiated Coverage$165.76$171.00Overweight
Liquidia Corporation stock logo
LQDA
Liquidia
10/20/2025Initiated Coverage$22.48$31.00Overweight
MannKind Corporation stock logo
MNKD
MannKind
10/20/2025Initiated Coverage$5.47$10.00Overweight
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
10/20/2025Initiated Coverage$65.95$73.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
10/20/2025Initiated Coverage$32.63$65.00Overweight
Pentagon magnet restrictions take effect January 1, 2027 (Ad)

A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027.tc pixel

Read the full breakdown of the proposed Army rare earth agreement and the company behind it.
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
10/20/2025Initiated Coverage$433.34$414.00Underweight
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
10/20/2025Initiated Coverage$7.81$18.00Overweight
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
9/4/2025Lower Price Target$8.00$18.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
9/3/2025Boost Price Target$145.30$171.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
9/3/2025Boost Price Target$404.27$414.00Equal Weight
MannKind Corporation stock logo
MNKD
MannKind
9/3/2025Boost Price Target$5.63$10.00Overweight
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
8/20/2025Lower Price Target$48.30$73.00Overweight
Liquidia Corporation stock logo
LQDA
Liquidia
8/13/2025Boost Price Target$24.10$31.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
8/12/2025Boost Price Target$122.00$140.00Overweight
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
8/8/2025Boost Price Target$46.28$79.00Overweight
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
8/1/2025Boost Price Target$395.93$395.00Equal Weight
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
7/31/2025Lower Price Target$8.32$21.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
7/31/2025Lower Price Target$278.91$295.00Equal Weight
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
7/29/2025Boost Price Target$48.86$78.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
7/22/2025Boost Price Target$103.27$130.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
7/10/2025Lower Price Target$30.25$65.00Overweight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
6/30/2025Boost Price Target$44.24$76.00Overweight
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
6/30/2025Boost Price Target$324.99$333.00Equal Weight
Liquidia Corporation stock logo
LQDA
Liquidia
6/12/2025Boost Price Target$14.13$25.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
6/11/2025Boost Price Target$90.93$119.00Overweight
Savara Inc. stock logo
SVRA
Savara
5/28/2025Lower Price Target$2.07$7.00Overweight
Liquidia Corporation stock logo
LQDA
Liquidia
5/28/2025Boost Price Target$15.40$23.00Overweight
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
5/27/2025Boost Price Target$45.93$74.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
4/25/2025Reiterated Rating$296.42$314.00Equal Weight
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
3/21/2025Boost Price Target$253.60$287.00Equal Weight
Tectonic Therapeutic, Inc. stock logo
TECX
Tectonic Therapeutic
3/21/2025Lower Price Target$20.58$101.00Overweight
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
3/4/2025Lower Price Target$1.38$3.00Equal Weight
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
2/27/2025Lower Price Target$11.35$26.00Overweight
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
2/20/2025Lower Price Target$9.56$17.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
2/19/2025Boost Price Target$81.36$107.00Overweight
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
2/10/2025Downgrade$7.79$4.00Equal Weight
Tectonic Therapeutic, Inc. stock logo
TECX
Tectonic Therapeutic
1/31/2025Boost Price Target$59.23$112.00Overweight
Liquidia Corporation stock logo
LQDA
Liquidia
12/20/2024Initiated Coverage$10.59$20.00Overweight
MannKind Corporation stock logo
MNKD
MannKind
12/20/2024Initiated Coverage$6.30$9.00Overweight
Savara Inc. stock logo
SVRA
Savara
12/20/2024Initiated Coverage$3.23$8.00Overweight